M&A Deal Summary |
|
---|---|
Date | 2013-07-23 |
Target | Advanced Liquid Logic |
Sector | Medical Products |
Buyer(s) | Illumina |
Deal Type | Add-on Acquisition |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 1998 |
Sector | Life Science |
Employees | 10,590 |
Revenue | 4.5B USD (2023) |
Illumina is a developer, manufacturer, and marketer of life science tools and integrated systems for the analysis of genetic variation and function. Illumina provides innovative sequencing and array-based solutions for genotyping, copy number variation analysis, methylation studies, gene expression profiling, and low-multiplex analysis of DNA, RNA, and protein. The Company's customers include genomic research centers, academic institutions, government laboratories, hospitals, and reference laboratories as well as pharmaceutical, biotechnology, agrigenomics, commercial molecular diagnostic, and consumer genomics companies. Illumina was formed in 1998 and is based in San Diego, California.
DEAL STATS | # |
---|---|
Overall | 6 of 29 |
Sector (Medical Products) | 2 of 3 |
Type (Add-on Acquisition) | 6 of 14 |
State (North Carolina) | 1 of 1 |
Country (United States) | 5 of 20 |
Year (2013) | 2 of 3 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2013-01-07 |
Artemis Health
Salt Lake City, Utah, United States Artemis Health is a provider of benefits data analytics and healthcare analytics to self-insured employers, employee benefits consultants, and benefits brokers. Artemis Health was founded in 2002 and is based in Salt Lake City, Utah. |
Buy | $450M |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2013-10-28 |
NextBio
Santa Clara, California, United States NextBio, Inc. is a provider of clinical and genomic informatics. NextBio's powerful big-data platforms aggregate and analyze large quantities of phenotypic and genomic data for research and clinical applications. |
Buy | - |